Hendrick R Edward, Monticciolo Debra L
From the Department of Radiology, University of Colorado School of Medicine, 12401 E 17th Ave, Aurora, CO 80045 (R.E.H.); and Foundation for Imaging Research and Education, Temple, Tex (D.L.M.).
Radiology. 2024 Dec;313(3):e241397. doi: 10.1148/radiol.241397.
Background The incidence of distant-stage (metastatic) breast cancer at initial presentation has increased significantly in U.S. women under 40 years of age, but no clear trend in older women has been reported. Purpose To investigate trends in distant-stage breast cancer incidence using the latest available Surveillance, Epidemiology, and End Results (SEER) data, including the COVID-19 pandemic years 2020 and 2021. Materials and Methods In this retrospective study of 71 million to 80 million women annually, SEER 22 stage-specific breast cancer incidence rates from January 2004 to December 2021 were analyzed using Joinpoint software to evaluate trends in distant-stage disease in U.S. women overall, by age group, and by race and ethnicity. Results Distant-stage breast cancer incidence rates at presentation increased significantly for U.S. women overall, with an annual percentage change (APC) of 1.16% (95% CI: 0.92, 1.42; < .001) over 2004-2021. Distant-stage disease increased consistently for women aged 20-39 years (APC, 2.91%; < .001) and for women aged 75 years or older (APC, 1.44%; < .001). For women aged 40-74 years, the distant-stage breast cancer incidence rate increased with an APC of 2.10% over 2004-2010 ( = .002) and an APC of 2.73% over 2018-2021 ( = 0.01). The interruption of care in 2020 due to COVID-19 affected distant-stage breast cancer detection, especially for older women from racial and ethnic minority groups. The incidence of distant-stage breast cancer increased over 2004-2021 for Asian women (APC, 2.90%; < .001), Black women (0.86%; = .008), and Hispanic women (1.56%; < .001) and over 2004-2019 for Native American women (3.86%; = .04). White women showed an increase over 2004-2012 (1.68%; = .01) but no evidence of a trend over 2012-2021. Distant-stage cancer incidence rates were 55% higher in Black women than White women. Conclusion Distant-stage breast cancer incidence rates at presentation have increased significantly in U.S. women overall; in age groups 20-39 years, 40-74 years, and 75 years or older; and in Asian, Black, Hispanic, and Native American women. © RSNA, 2024 See also the editorial by Kim and Moy in this issue.
美国40岁以下女性初诊时远处转移期(转移性)乳腺癌的发病率显著增加,但老年女性中尚无明确趋势的报道。目的:利用最新的监测、流行病学和最终结果(SEER)数据,包括2020年和2021年新冠疫情期间的数据,调查远处转移期乳腺癌发病率的趋势。材料与方法:在这项每年对7100万至8000万女性进行的回顾性研究中,使用Joinpoint软件分析了2004年1月至2021年12月SEER 22个特定阶段的乳腺癌发病率,以评估美国女性总体、按年龄组以及按种族和族裔划分的远处转移期疾病趋势。结果:美国女性总体初诊时远处转移期乳腺癌发病率显著增加,2004 - 2021年的年百分比变化(APC)为1.16%(95%CI:0.92,1.42;P <.001)。20 - 39岁女性(APC,2.91%;P <.001)和75岁及以上女性(APC,1.44%;P <.001)的远处转移期疾病持续增加。对于40 - 74岁女性,2004 - 2010年远处转移期乳腺癌发病率以2.10%的APC增加(P =.002),2018 - 2021年以2.73%的APC增加(P = 0.01)。2020年因新冠疫情导致的医疗中断影响了远处转移期乳腺癌的检测,尤其是对来自少数族裔的老年女性。2004 - 2021年,亚洲女性(APC,2.90%;P <.001)、黑人女性(0.86%;P =.008)和西班牙裔女性(1.56%;P <.001)的远处转移期乳腺癌发病率增加,2004 - 2019年美国原住民女性(3.86%;P =.04)的发病率也增加。白人女性在2004 - 2012年增加(1.68%;P =.01),但在2012 - 2021年没有趋势证据。黑人女性的远处转移期癌症发病率比白人女性高55%。结论:美国女性总体、20 - 39岁、40 - 74岁和75岁及以上年龄组以及亚洲、黑人、西班牙裔和美国原住民女性初诊时远处转移期乳腺癌发病率显著增加。©RSNA,2024 另见本期Kim和Moy的社论。